United Therapeutics Corp. (UTHR) announced Monday morning that regulatory delays have forced it to postpone the planned U.S. launch of the RemoSynch Implantable System for Remodulin until 2018.
from RTT - Before the Bell http://ift.tt/2nEJWo6
via IFTTT
No comments:
Post a Comment